Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

Ann Neurol. 2011 Jan;69(1):215-6; author reply 216. doi: 10.1002/ana.22305.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • DNA, Viral / blood*
  • DNA, Viral / cerebrospinal fluid
  • DNA, Viral / urine
  • Follow-Up Studies
  • Humans
  • Integrin alpha4 / therapeutic use*
  • JC Virus / genetics
  • JC Virus / isolation & purification*
  • Leukoencephalopathy, Progressive Multifocal / virology*
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Polymerase Chain Reaction / standards
  • Polymerase Chain Reaction / statistics & numerical data
  • Risk Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • DNA, Viral
  • Natalizumab
  • Integrin alpha4